(Q36636663)

15 August 2017

1 reference

title

Sentinel lymph node biopsy as the new standard of care in the surgical treatment for breast cancer (English)

1 reference

15 August 2017

Alberta Ferrari

1

1 reference

15 August 2017

Francesca Rovera

2

1 reference

15 August 2017

Paolo Dionigi

3

1 reference

15 August 2017

Giorgio Limonta

4

1 reference

15 August 2017

Marina Marelli

5

1 reference

15 August 2017

Isabella Besana Ciani

6

1 reference

15 August 2017

Veronica Bianchi

7

1 reference

15 August 2017

Cristiana Vanoli

8

1 reference

15 August 2017

Renzo Dionigi

9

1 reference

15 August 2017

publication date

1 October 2006

1 reference

Expert Review of Anticancer Therapy

15 August 2017

published in

1 reference

15 August 2017

volume

6

1 reference

15 August 2017

issue

10

1 reference

15 August 2017

page(s)

1503-1515

1 reference

An approach for the treatment of penile carcinoma

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Comments on the St. Gallen Consensus 2003 on the Primary Therapy of Early Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Prospective evaluation of factors influencing success rates of sentinel node biopsy in 814 breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Using the intraoperative hand held probe without lymphoscintigraphy or using only dye correlates with higher sensory morbidity following sentinel lymph node biopsy in breast cancer: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Factors predicting failure to identify a sentinel lymph node in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Correlation of lymphoscintigraphy with the number of sentinel lymph nodes identified intraoperatively in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Subareolar injection of 99mTc facilitates sentinel lymph node identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Subareolar versus peritumoral injection for location of the sentinel lymph node

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Subareolar injection is a better technique for sentinel lymph node biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Guidelines to assure quality in breast cancer surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Modifications of the learning curve guidelines for breast cancer sentinel node biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Improved axillary staging of breast cancer with sentinel lymphadenectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Improving the reproducibility of diagnosing micrometastases and isolated tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Revision of the American Joint Committee on Cancer staging system for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

The sentinel lymph node biopsy under local anesthesia in breast carcinoma: experience of the European Institute of Oncology and impact on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Lymphatic mapping and sentinel lymph node biopsy for breast cancer: developments and resolving controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Sentinel lymph node biopsy in patients with multifocal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Sentinel lymph node drainage in multicentric breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Sentinel node biopsy in ductal carcinoma in situ patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Safety of sentinel node biopsy in pregnant patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Occult axillary lymph node metastases are of no prognostic significance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.10.1503

10.1586/14737140.6.10.1503

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference